Veron Sanchez A, Bennouna I, Coquelet N, Cabo Bolado J, Pinilla Fernandez I, Mullor Delgado L
Diagnostics (Basel). 2023; 13(13).
PMID: 37443647
PMC: 10340753.
DOI: 10.3390/diagnostics13132253.
Montanarella M, Boldig K, Virarkar M, Kumar S, Elsherif S, Lall C
J Clin Imaging Sci. 2023; 13:13.
PMID: 37292244
PMC: 10246409.
DOI: 10.25259/JCIS_29_2023.
Giamougiannis P, Morais C, Grabowska R, Ashton K, Wood N, Martin-Hirsch P
Anal Bioanal Chem. 2020; 413(3):911-922.
PMID: 33242117
PMC: 7808972.
DOI: 10.1007/s00216-020-03045-1.
Sureka B, Meena V, Garg P, Yadav T, Khera P
Pol J Radiol. 2019; 83:e500-e509.
PMID: 30655930
PMC: 6334186.
DOI: 10.5114/pjr.2018.80247.
Krishnamurthy S, Balasubramaniam R
Indian J Surg Oncol. 2016; 7(4):441-452.
PMID: 27872533
PMC: 5097766.
DOI: 10.1007/s13193-016-0539-8.
Intrapericardial bevacizumab safely and effectively treats malignant pericardial effusion in advanced cancer patients.
Chen D, Zhang Y, Shi F, Zhu H, Li M, Luo J
Oncotarget. 2016; 7(32):52436-52441.
PMID: 27203219
PMC: 5239564.
DOI: 10.18632/oncotarget.9420.
Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment.
Kuracha M, Thomas P, Loggie B, Govindarajan V
Cancer Med. 2016; 5(4):711-9.
PMID: 26833741
PMC: 4831290.
DOI: 10.1002/cam4.640.
Pathological Characterization of Ovarian Cancer Patients Who Underwent Debulking Surgery in Combination With Diaphragmatic Surgery: A Cross-Sectional Study.
Nagai T, Oshiro H, Sagawa Y, Sakamaki K, Terauchi F, Nagao T
Medicine (Baltimore). 2015; 94(50):e2296.
PMID: 26683966
PMC: 5058938.
DOI: 10.1097/MD.0000000000002296.
Soluble EpCAM levels in ascites correlate with positive cytology and neutralize catumaxomab activity in vitro.
Seeber A, Martowicz A, Spizzo G, Buratti T, Obrist P, Fong D
BMC Cancer. 2015; 15:372.
PMID: 25947366
PMC: 4427982.
DOI: 10.1186/s12885-015-1371-1.
Gynecologic tumors: how to communicate imaging results to the surgeon.
Rizzo S, Calareso G, De Maria F, Zanagnolo V, Lazzari R, Cecconi A
Cancer Imaging. 2014; 13(4):611-25.
PMID: 24434038
PMC: 3894699.
DOI: 10.1102/1470-7330.2013.0054.
Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research.
Ahmed N, Stenvers K
Front Oncol. 2013; 3:256.
PMID: 24093089
PMC: 3782691.
DOI: 10.3389/fonc.2013.00256.
Hepatic Resection is Safe for Metachronous Hepatic Metastases from Ovarian Cancer.
Niu G, Shen C, Cui W, Li Q
Cancer Biol Med. 2013; 9(3):182-7.
PMID: 23691476
PMC: 3643668.
DOI: 10.7497/j.issn.2095-3941.2012.03.005.
Value of ascitic fluid cholesterol and serum-ascites albumin gradient in differentiating cirrhotic and malignancy related ascites.
Bijoor A, Venkatesh T
Indian J Clin Biochem. 2012; 16(1):106-9.
PMID: 23105301
PMC: 3453610.
DOI: 10.1007/BF02867577.
Clinical relevance of multidrug resistance gene expression in ovarian serous carcinoma effusions.
Gillet J, Wang J, Calcagno A, Green L, Varma S, Elstrand M
Mol Pharm. 2011; 8(6):2080-8.
PMID: 21761824
PMC: 3224865.
DOI: 10.1021/mp200240a.
Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination.
Moss N, Barbolina M, Liu Y, Sun L, Munshi H, Stack M
Cancer Res. 2009; 69(17):7121-9.
PMID: 19706774
PMC: 2737080.
DOI: 10.1158/0008-5472.CAN-08-4151.
Disaggregation and invasion of ovarian carcinoma ascites spheroids.
Burleson K, Boente M, Pambuccian S, Skubitz A
J Transl Med. 2006; 4:6.
PMID: 16433903
PMC: 1397876.
DOI: 10.1186/1479-5876-4-6.
Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers.
Burleson K, Hansen L, Skubitz A
Clin Exp Metastasis. 2005; 21(8):685-97.
PMID: 16035613
DOI: 10.1007/s10585-004-5768-5.
Solitary cerebral metastases from ovarian epithelial carcinoma: 11 cases.
DAndrea G, Roperto R, Dinia L, Caroli E, Salvati M, Ferrante L
Neurosurg Rev. 2004; 28(2):120-3.
PMID: 15558348
DOI: 10.1007/s10143-004-0363-4.
Modulation of human ovarian tumor cell sensitivity to N-(phosphonacetyl)-L-aspartate (PALA) by liposome drug carriers.
Sharma A, Straubinger N, Straubinger R
Pharm Res. 1993; 10(10):1434-41.
PMID: 8272404
DOI: 10.1023/a:1018963006703.
Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon.
Sugarbaker P
Ann Surg. 1994; 219(2):109-11.
PMID: 8129480
PMC: 1243111.
DOI: 10.1097/00000658-199402000-00001.
